| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Gland Pharma Limited (NSE: GLAND)
GLAND Technical Analysis
2
| As on 25th Apr 2024 GLAND SHARE Price closed @ 1738.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1593.96 & Strong Sell for SHORT-TERM with Stoploss of 1830.37 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GLANDSHARE Price
| Open | 1770.00 | Change | Price | % |
| High | 1780.80 | 1 Day | -18.10 | -1.03 |
| Low | 1736.00 | 1 Week | -25.80 | -1.46 |
| Close | 1738.60 | 1 Month | -55.75 | -3.11 |
| Volume | 74251 | 1 Year | 388.90 | 28.81 |
| 52 Week High 3448.70 | 52 Week Low 893.55 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| GLAND Daily Charts |
GLAND Intraday Charts |
Whats New @ Bazaartrend |
GLAND Free Analysis |
|
|
GLAND Important Levels Intraday
| RESISTANCE | 1824.93 |
| RESISTANCE | 1797.24 |
| RESISTANCE | 1780.13 |
| RESISTANCE | 1763.02 |
| SUPPORT | 1714.18 |
| SUPPORT | 1697.07 |
| SUPPORT | 1679.96 |
| SUPPORT | 1652.27 |
GLAND Target April 2024
| 4th UP Target | 2676.09 |
| 3rd UP Target | 2391.13 |
| 2nd UP Target | 2214.99 |
| 1st UP Target | 2038.85 |
| 1st DOWN Target | 1536.25 |
| 2nd DOWN Target | 1360.11 |
| 3rd DOWN Target | 1183.97 |
| 4th DOWN Target | 899.01 |
GLAND Weekly Target
| 4th UP Target | 1958.03 |
| 3rd UP Target | 1895.68 |
| 2nd UP Target | 1857.13 |
| 1st UP Target | 1818.59 |
| 1st DOWN Target | 1708.61 |
| 2nd DOWN Target | 1670.07 |
| 3rd DOWN Target | 1631.52 |
| 4th DOWN Target | 1569.17 |
GLAND Target2024
| 4th UP Target | 5082.76 |
| 3rd UP Target | 4069.89 |
| 2nd UP Target | 3443.81 |
| 1st UP Target | 2817.73 |
| 1st DOWN Target | 1031.27 |
| 2nd DOWN Target | 405.19 |
| 3rd DOWN Target | -220.89 |
| 4th DOWN Target | -1233.76 |
Gland Pharma Limited ( NSE INDIA Symbol : GLAND )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GLAND Synopsis Technicals View
| 50 Day EMA |
N/A (Short Term) |
N/A | |
| 100 Day EMA | N/A (Mid Term) | N/A | |
| 200 Day EMA | N/A (Long Term) | N/A | |
| MACD (12 26 9) | N/A | N/A | |
| RSI (14) | N/A | N/A | |
| MFI (14) | N/A | N/A | |
| CCI (20) | N/A | N/A | |
| WILLIAM %R (14) | N/A | N/A | |
| ADX (14) | N/A | N/A | |
| PSAR | N/A | N/A | |
| 10 Day Avg Volume | N/A | ||
GLAND Other Details
| Segment | EQ | |
| Market Capital | 588151848960.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-General | |
| Offical website | > | |
GLAND Address
 |
||
GLAND Latest News
GLAND Business Profile
Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd. Address: Plot No. 11 & 84, TSIIC Phase: IV, Hyderabad, India, 502307
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service